Product Overview
[Drug Name]
Generic Name: Telmisartan Hydrochlorothiazide Capsules
Trade Name: XinSuoKa Telmisartan Hydrochlorothiazide Capsules 40mg: 12.5mg*14 capsules
Pinyin Full Code: XinSuoKa TiMiShaTanQingLvZuoZuoJiaoNang 40mg: 12.5mg*14Li
[Main Ingredients]
This product is a combination preparation. Each capsule contains 40mg of telmisartan and 12.5mg of hydrochlorothiazide.
[Properties]
This product is a capsule containing off-white or light yellow granules.
[Indications/Main Functions]
For the treatment of hypertension. This product is not suitable for the initial treatment of hypertension.
[Precautions]
See package insert for details.
[Drug Interactions]
Contraindicated in: 1. Patients allergic to any ingredient in this product. 2. Patients with anuria and allergies to other thiamine derivatives. 3. Allergies to other angiotensin receptor antagonists. 4. Patients with biliary obstructive disease. 5. Patients with severe hepatic insufficiency. 6. Patients with severe renal insufficiency. 7. Pregnant and lactating women.
[Specifications]
40mg: 12.5mg x 14 capsules
[Dosage and Administration]
To minimize dose-independent side effects, combination therapy is generally only used when monotherapy fails to achieve satisfactory results. If blood pressure is not effectively controlled with telmisartan 80mg alone, or if blood pressure is uncontrolled with hydrochlorothiazide 25mg once daily, or if blood pressure is controlled but hypokalemia develops, consider switching to telmisartan hydrochlorothiazide capsules (i.e., 40mg telmisartan/12.5mg hydrochlorothiazide), one tablet once daily. The dose can be increased to a maximum of 160mg/25mg if necessary. Telmisartan should be used in patients with hypovolemia after blood volume correction or under close medical supervision. Patients with biliary obstruction or impaired liver function must be initially treated under close medical supervision. Telmisartan Hydrochlorothiazide Capsules can be taken before or after meals, alone or in combination with other antihypertensive medications. Patients with Impaired Renal Function: Conventional treatment with this drug requires a creatinine clearance of 30 ml/min or higher. This drug is not recommended for patients with severe renal impairment, as loop diuretics are often used. Patients with Impaired Liver Function: This drug is not recommended for patients with severe liver impairment. Patients with biliary obstruction or impaired liver function should initiate this drug at a dose of 40 mg/12.5 mg under close medical supervision.
[Adverse Reactions]
See package insert for details.
[Contraindications]
This drug is contraindicated in: 1. Patients with hypersensitivity to any of the ingredients in this drug. 2. Patients with anuria and those allergic to other thiamine derivatives. 3. Patients allergic to other angiotensin receptor antagonists. 4. Patients with biliary obstructive disease. 5. Patients with severe hepatic insufficiency. 6. Patients with severe renal insufficiency. 7. Pregnant and breastfeeding women.
